Product Recalls in Vermont

Product recalls affecting Vermont — including food, drugs, consumer products, medical devices, and vehicles distributed to Vermont. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 1,054 recalls have been distributed to Vermont in the last 12 months.

47,027 total recalls
1,054 in last 12 months

Showing 9001–9020 of 47,027 recalls

DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Timolol Maleate Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Lorazepam Injection Recalled by Akorn, Inc. Due to CGMP Deviations: Firm...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Prednisolone Oral Solution Recalled by Akorn, Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Gadget Island, Inc

Recalled Item: NUX Male Enhancement capsule Recalled by Gadget Island, Inc Due to...

The Issue: Marketed without an Approved NDA/ANDA: FDA analysis found product to be...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Fentanyl Citrate Injection Recalled by Akorn, Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Diuril (chlorothiazide sodium) Injection Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: AK-POLY-BAC (bacitracin Zinc and Polymyxin B Sulfate) Ophthalmic Ointment...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Ropivacaine Hydrochloride Injection USP Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Ephedrine Sulfate Injection Recalled by Akorn, Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Olopatadine HCl Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Cetrorelix Acetate for Injection Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Lidocaine HCl Jelly USP Recalled by Akorn, Inc. Due to CGMP Deviations: Firm...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Sodium Chloride Ophthalmic Ointment Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Tobramycin Inhalation Solution USP Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: HydrALAZINE HCl Injection Recalled by Akorn, Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Guaiatussin AC Sugar-Free Recalled by Akorn, Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Hydrocortisone and Acetic Acid Otic Solution Recalled by Akorn, Inc. Due to...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Sulfamethoxazole & Trimethoprim Oral Suspension USP Recalled by Akorn, Inc....

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Lorazepam Oral Concentrate Recalled by Akorn, Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Lactulose Solution Recalled by Akorn, Inc. Due to CGMP Deviations: Firm went...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund